22 June 2017 | News | By BioSpectrum Bureau
This surgical instrument enables surgeons to prepare the sacroiliac (SI) joint for fusion by creating bleeding bone and space for autologous bone graft.
Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent representing continued advancement of the SImmetry Sacroiliac Joint Fusion System.
US patent number 9,662,124 relates to the design of the company's proprietary SImmetry Decorticator. This surgical instrument enables surgeons to prepare the sacroiliac (SI) joint for fusion by creating bleeding bone and space for autologous bone graft. This is accomplished through a minimally-invasive, lateral approach that avoids disruption of supporting ligaments around the SI joint.
"Zyga remains committed to advancing true fusion technology and the field of SI joint fusion," said Jim Bullock, president and CEO of Zyga. "Zyga now has seven issued patents related to preparing the SI joint to establish a true biologic fusion. The expansion of our intellectual property and ongoing support of clinical trials such as the EVoluSIon study further demonstrate Zyga's leadership in innovation for minimally-invasive spine surgery."
The Centers for Disease Control and Prevention lists back problems as the second most common cause of disability in U.S. adults. It has been reported that approximately 20 percent of all chronic LBP derives from the sacroiliac joint.